Skip to main navigation
Repare Therapeutics
  • Company
    • About Us
    • Leadership
    • Partnering
    • Contact
  • Science
    • Therapeutic Focus
    • Scientific References
  • Pipeline
    • Development Pipeline
    • Polθ Inhibitor
    • RP-1664 PLK4 inhibitor
    • Camonsertib ATR Inhibitor
  • Clinical Trials
    • Clinical Trials Overview
    • Expanded Access Policy
  • Careers
    • Job Opportunities
    • Our Culture
  • Investors & Media
    • Corporate Profile
    • Press Releases
    • Events & Presentations
      • Events
      • Presentations
    • Stock Information
      • Stock Quote & Chart
      • Analyst Coverage
    • SEC Filings
    • Corporate Governance
      • Documents & Charters
      • Management Team
      • Board of Directors
      • Committee Composition
      • Contact the Board
      • Entity report pursuant to Bill S-211
    • Investor Resources
      • Investor FAQs
      • Investor Email Alerts
      • PFIC Statement
      • Contact IR
Select Page

SEC Filing Details

SEC Filing Details

Document Details

Form
10-K
Filing Date
Feb 28, 2023
Document Date
Dec 31, 2022
Form Description
Annual report which provides a comprehensive overview of the company for the past year
Filing Group
Annual Filings
Company
Repare Therapeutics
Issuer
REPARE THERAPEUTICS INC.

Filing Formats

iXBRL
View HTML
Download PDF
Download DOC
Download XLS

XBRL

XBRL Viewer
EX-101.CAL - XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
EX-101.LAB - XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
EX-101.DEF - XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
XML - XBRL INSTANCE DOCUMENT
Media & IR Contact
Investor Relations & Media Contact

Steve Forte
Contact Us

Helpful Tools
  • Print Page
  • Email Alerts
  • RSS Feeds
Company
  • About Us
  • Leadership
  • Partnering
  • Contact
Science
  • Therapeutic Focus
  • Scientific References
Pipeline
  • Development Pipeline
  • Polθ Inhibitor
  • RP-1664 PLK4 inhibitor
  • Camonsertib ATR Inhibitor
Clinical Trials
  • Clinical Trials Overview
  • Expanded Access Policy
Careers
  • Job Opportunities
  • Our Culture
Investors & Media
  • Corporate Profile
  • Press Releases
  • Events & Presentations
  • Stock Information
  • SEC Filings
  • Corporate Governance
  • Investor Resources
Repare Therapeutics logo
© 2025 Repare Therapeutics
  • Privacy Policy
  • Terms of Use
  • Cookie Policy